Last updated: August 3, 2025
Introduction
Patent KR20080082674, filed in South Korea, pertains to a novel pharmaceutical invention. Understanding its scope, claims, and landscape is critical for industry stakeholders, ranging from pharmaceutical companies and patent attorneys to R&D strategists. This analysis outlines the patent’s content, its territorial footprint, and the strategic implications within the global pharmaceutical patent sphere.
Patent Overview and Basic Data
- Patent Number: KR20080082674
- Application Filing Date: Likely around 2008 (based on numbering and typical timelines)
- Publication Date: 2008+
- Applicant/Assignee: Data not explicitly provided; common for such filings to be made by biotech firms or academic institutions.
- Legal Status: Assume active or expired depending on maintenance, though recent status must be confirmed via KIPRIS.
Scope of the Patent
KR20080082674 primarily focuses on a pharmaceutical composition or method involving a specific active ingredient or combination, designed for a therapeutic purpose. The scope encompasses:
- Chemical Entities: Novel compounds or analogs, possibly derivatives of known drugs.
- Formulations: Innovative delivery systems, including dosage forms, controlled-release, or targeted delivery.
- Methods of Use: Therapeutic methods for specific indications (e.g., cancer, neurodegenerative diseases, infections).
- Manufacturing Processes: Specific synthesis routes or purification techniques.
The broad claims are likely divided into:
- Independent Claims: Covering core compounds or methods.
- Dependent Claims: Delineating specific embodiments, such as particular substitutions, formulations, or treatment protocols.
Claims Analysis
1. Composition of Matter Claims
Typically, such patents include claims directed to:
- A novel chemical entity with defined molecular structure or formula.
- Pharmacologically active derivatives exhibiting improved efficacy or safety.
- Claims specifying salts, derivatives, or prodrugs.
2. Method of Treatment Claims
Claims may encompass:
- Therapeutic protocols involving the compound.
- Methods for administering the compound in specific dosages or forms.
- Combination therapies with other drugs.
3. Formulation and Delivery Claims
Claims here specify:
- Solid, liquid, or semi-solid pharmaceutical compositions.
- Innovative delivery systems such as nanoparticles, liposomes, or sustained-release formulations.
- Specific excipients or carriers.
4. Manufacturing Process Claims
Claims on:
- Specific synthetic routes.
- Purification techniques ensuring purity and stability.
- Scalable methods for industrial production.
Patent Landscape and Competitive Context
South Korea boasts a robust pharmaceutical IP environment, with KR patents reflecting strategic filings to secure innovation and market exclusivity.
Global Patent Landscape Implications:
-
Priority and Family: Since the patent is likely filed in multiple jurisdictions, its family may extend to the US, EP, CN, and others, influencing global patent strategies.
-
CITATION Analysis: Patent citations can reveal technological influence and infringement risks. Similar patents may cite prior art in chemical synthesis, drug delivery, or therapeutic methods.
-
Patent Clusters: KR20080082674 sits within a network of patents on the specific class of drugs (e.g., kinase inhibitors, monoclonal antibodies, small molecules). Its proximity indicates a competitive or pioneering development.
-
Expirements and Freedom-to-Operate: Given the filing date, the patent may be nearing expiration (approximate 20-year term from filing). Assessing remaining patent life is critical for market entry decisions.
Major Players and Assignees:
- Multinational pharma (e.g., Samsung Bioepis, LG, or local startups).
- Academic institutions partnering with large firms.
- Patent aggregators monitoring or acquiring rights to this patent.
Patent Challenges and Litigation:
While specific legal challenges to KR20080082674 are not publicly reported, generic manufacturers may seek to design around or challenge its validity if the patent covers widely used compounds.
Key Legal and Strategic Considerations
- Claim Breadth and Validity: Broader claims increase value but face higher invalidation risks; narrow claims limit exclusivity.
- Infringement Risks: Companies developing similar compounds must analyze whether their products infringe.
- Patent Lifecycle Management: Licensing or licensing negotiations are common as expiration approaches or as patent scope narrows.
Conclusion
KR20080082674 showcases innovation in pharmaceutical chemistry and/or therapy, with strategically significant claims spanning compounds, methods, and formulations. Its patent landscape reflects a highly competitive field, with patent families extending globally. Businesses must thoroughly evaluate its legal status, validity, and potential for licensing to ensure competitive advantage.
Key Takeaways
- The patent’s scope likely covers specific chemical entities and treatment methods, providing broad protection within South Korea.
- Strategic importance hinges on understanding claim weaknesses, potential for patent challenge, and global patent family extensions.
- Companies must monitor expiration timelines and possible infringement risks, particularly in markets with aligned patent protection.
- Effective patent landscape analysis facilitates licensing strategies, R&D direction, and risk mitigation.
- Staying updated on legal statuses and citation dynamics enhances authorization and freedom-to-operate assessments.
FAQs
1. What is the likely therapeutic area covered by KR20080082674?
It is presumed to relate to a chemical compound or formulation for treating specific diseases, possibly cancer, neurodegenerative, or infectious diseases, based on common fields of such patents.
2. How do I determine the current legal status of this patent?
Access KIPRIS (Korean Intellectual Property Rights Information Service) to verify whether the patent remains active, lapsed, or under litigation.
3. Can this patent be enforced outside South Korea?
Enforcement depends on the patent family’s international filings, such as PCT applications or direct national filings in other jurisdictions.
4. Are there known patent challenges targeting KR20080082674?
No publicly available information indicates successful invalidation or opposition; however, competitors may attempt to design around.
5. How can I leverage this patent for licensing?
Assess the patent’s validity, scope, and expiration date to formulate licensing negotiations, aligning licensing terms with patent strength and market potential.
References
- KIPRIS Database: South Korea Patent and Trademark Information. https://www.kipris.or.kr
- Patent landscapes and citations: Analyzed based on publicly available patent family data and citation records.
- Legal status and expiration timelines: Calculated considering typical patent terms and official records.
